Thursday, January 19, 2017 12:00 p.m. ET
Join Reed Smith partners Keri Bruce and Kevin Madagan for this webinar as they address the legal liability and responsibility of a drug or device company incorporating any user-generated content (UGC) features on websites or within social media channels owned or controlled by the company.
Among other things, attendees will learn about the Communications Decency Act (CDA), a federal law that makes an Internet service provider immune from liability related to UGC under many circumstances, as long as the provider is not controlling the statements to such a degree it makes them its own. FDA policy, and statements regarding the CDA and social media will also be explored, as well as the interplay between the CDA and the Food, Drug, and Cosmetic Act.